PepperLime Health Acquisition Corporation (PEPLU) Stock Analysis

Why this analysis is different

• A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

PepperLime Health Acquisition Corporation (PEPLU) Financial Services Profile

PepperLime Health Acquisition Corporation, a special purpose acquisition company (SPAC) incorporated in 2021, is actively pursuing a merger, share exchange, or asset acquisition within the broader financial services sector, aiming to bring a private entity to the public market.

What Is the Investment Thesis for PEPLU?

PepperLime Health Acquisition Corporation presents a speculative investment opportunity tied to its ability to identify and successfully merge with a promising private company. As of March 18, 2026, the company's market capitalization stands at $0.06 billion, with a P/E ratio of 56.11 and a beta of 0.01. The absence of a dividend reflects its current status as a shell company focused on deal execution. The investment thesis hinges on the management team's expertise in deal sourcing and execution, as well as the attractiveness of the target company they ultimately select. Key risks include the failure to complete a merger within the specified timeframe, which could lead to liquidation, and the potential for the acquired company to underperform expectations.

Based on FMP financials and quantitative analysis

PEPLU Key Highlights

Market capitalization of $55.1M indicates the company's current valuation as a SPAC.

• P/E ratio of 56.11 reflects market expectations regarding the potential merger target's future earnings.
• Beta of 0.01 suggests low volatility relative to the overall market, typical for SPACs awaiting a merger announcement.
• Absence of dividend payout is standard for SPACs, as capital is reserved for acquisition purposes.
• Incorporated in 2021, PepperLime Health Acquisition Corporation is still within the typical timeframe for SPACs to identify and complete a merger.

Who Are PEPLU's Competitors?

PEPLU is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are PEPLU's Key Strengths?

Experienced management team.

• Access to capital through IPO.
• Flexibility to pursue a wide range of target companies.

What Are PEPLU's Weaknesses?

Dependence on identifying and completing a successful merger.

• Limited operating history.
• Potential for conflicts of interest.

What Could Drive PEPLU Stock Higher?

Announcement of a definitive merger agreement with a target company.

• Progress in due diligence and negotiations with potential merger candidates.
• Favorable market conditions for SPAC mergers and acquisitions.

What Are the Key Risks for PEPLU?

Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.

• Failure to identify and complete a merger within the specified timeframe, leading to liquidation.
• Underperformance of the acquired company after the merger.
• Changes in regulatory environment impacting SPACs.
• Increased competition for attractive merger targets.

What Are the Growth Opportunities for PEPLU?

• Successful Merger Completion: PepperLime Health Acquisition Corporation's primary growth opportunity lies in identifying and completing a merger with a high-growth private company. The potential market capitalization of the combined entity will depend on the target's industry, financial performance, and growth prospects. The timeline for completing a merger is typically within 24 months of the IPO, placing the target completion date around 2023-2024. A successful merger would drive shareholder value and validate the SPAC's investment thesis.
• Strategic Target Selection: The selection of a strategic target within a high-growth sector represents a significant growth opportunity. By focusing on industries with strong tailwinds, such as technology, healthcare, or renewable energy, PepperLime Health Acquisition Corporation can enhance the potential for long-term value creation. The market size of the target industry will influence the combined entity's growth potential. The timeline for identifying and securing a strategic target is ongoing, with continuous evaluation of potential candidates.
• Operational Improvements Post-Merger: Following the completion of a merger, implementing operational improvements within the acquired company can drive further growth. By leveraging its expertise and resources, PepperLime Health Acquisition Corporation can help the target company optimize its operations, improve its financial performance, and accelerate its growth trajectory. The timeline for implementing operational improvements is typically within the first 12-24 months after the merger.
• Access to Public Markets: Facilitating access to public markets for a private company represents a key growth opportunity. By merging with PepperLime Health Acquisition Corporation, the target company gains access to a broader investor base, increased liquidity, and enhanced visibility. This can enable the company to raise additional capital, pursue strategic acquisitions, and accelerate its growth plans. The timeline for realizing the benefits of public market access is ongoing, with continuous engagement with investors and analysts.
• Enhanced Valuation: The merger with PepperLime Health Acquisition Corporation can lead to an enhanced valuation for the target company. By leveraging the SPAC's financial resources and expertise, the target company can achieve a higher valuation than it might have otherwise obtained through a traditional IPO or private equity transaction. The timeline for realizing an enhanced valuation is dependent on the target company's performance and market conditions.

What Opportunities Does PEPLU Have?

• Growing market for SPACs.
• Increasing number of private companies seeking to go public.
• Potential to generate significant returns for shareholders.

What Threats Does PEPLU Face?

• Increased competition from other SPACs.
• Regulatory changes impacting the SPAC market.
• Economic downturn affecting the ability of target companies to perform.

What Are PEPLU's Competitive Advantages?

• Management team's experience in deal sourcing and execution.
• Access to capital through the IPO.
• Ability to identify and attract high-growth private companies.

What Does PEPLU Do?

PepperLime Health Acquisition Corporation, established in 2021 and headquartered in San Francisco, operates as a special purpose acquisition company (SPAC). The company's primary objective is to identify and merge with a private entity, thereby facilitating its entry into the public market. PepperLime Health Acquisition Corporation does not have any specific business operations of its own. Instead, it raises capital through an initial public offering (IPO) with the intention of using those funds to acquire or merge with an existing company. The company focuses on identifying target businesses through extensive research and due diligence. Once a target is identified, PepperLime Health Acquisition Corporation negotiates the terms of the merger or acquisition, which must then be approved by the SPAC's shareholders. Upon successful completion of a transaction, the private company becomes publicly traded under a new ticker symbol, while PepperLime Health Acquisition Corporation ceases to exist as a separate entity. The company's success hinges on its ability to identify and merge with a high-growth, attractive business that will deliver value to its shareholders.

What Products and Services Does PEPLU Offer?

• Identify potential merger or acquisition targets.
• Conduct due diligence on target companies.
• Negotiate merger or acquisition terms.
• Raise capital through an initial public offering (IPO).
• Seek shareholder approval for the proposed merger or acquisition.
• Complete the merger or acquisition transaction.

How Does PEPLU Make Money?

• Raise capital through an IPO.
• Identify and merge with a private company.
• Generate returns for shareholders through the growth of the acquired company.

What Industry Does PEPLU Operate In?

PepperLime Health Acquisition Corporation operates within the shell company industry, a segment of the financial services sector characterized by special purpose acquisition companies (SPACs). These companies are formed to raise capital through an IPO and subsequently acquire or merge with an existing private company, effectively taking it public. The SPAC market has experienced periods of rapid growth and increased scrutiny, with regulatory changes and market volatility impacting deal flow and investor sentiment. The competitive landscape includes numerous SPACs, each vying to identify and secure attractive merger targets. The success of a SPAC depends on the quality of its management team, its ability to conduct thorough due diligence, and the attractiveness of the target company.

Who Are PEPLU's Key Customers?

• Investors in the initial public offering (IPO).
• Shareholders who approve the merger or acquisition.
• The private company that merges with the SPAC.

Company Profile

PepperLime Health Acquisition Corporation operates in the Shell Companies industry within the Financial Services sector. It is headquartered in San Francisco, US. The company is led by CEO Ramzi Haidamus. PEPLU has traded publicly since 2021.

How PepperLime Health Acquisition Corporation Is Valued

PepperLime Health Acquisition Corporation carries a market capitalization of $55.1M, placing it in the micro-cap category. Relative to its peer group, PEPLU's quantitative score of 44/100 is below the peer average of 56/100.

Return on equity for PepperLime Health Acquisition Corporation stands at 2.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 1.9%, showing how much profit it generates from its asset base. PEPLU trades at a trailing price-to-earnings ratio of 56.11, above the Financial Services sector average of ~18x. Its free cash flow yield is -0.8%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.78 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 1.8%, the inverse of the P/E and a quick read on earnings relative to price.

PepperLime Health Acquisition Corporation's Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 3.56 places it in the safe zone, indicating low near-term bankruptcy risk.

PEPLU Financials

PEPLU Latest News

No recent news available for PEPLU.

PEPLU Analyst Consensus

PEPLU MoonshotScore

PEPLU Financial Services Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources